Jaguar Health (JAGX) Research & Development (2014 - 2026)
Jaguar Health (JAGX) reported Research & Development of $3.9 million for Q1 2026, up 5.31% year-over-year from $3.7 million in Q1 2025, and down 72.56% quarter-over-quarter from $14.3 million in Q4 2025.
Jaguar Health (JAGX) Research & Development (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Research & Development data on file, last reported at $3.9 million in Q1 2026.
- Research & Development for Q1 2026 came in at $3.9 million, up 5.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.2 million (up 57.67% YoY), and the FY2025 annual result was $25.0 million, up 50.92% from the prior year.
- Research & Development fell to $3.9 million in Q1 2026 per JAGX's latest filing, from $14.3 million in the prior quarter.
- Over five years, Research & Development peaked at $14.3 million in Q4 2025 and troughed at $2.5 million in Q2 2022.
- A 5-year average of $4.8 million and a median of $4.3 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development plunged 36.67% in 2022, then soared 215.68% in 2025.
- A 5-year view of Research & Development shows it stood at $4.3 million in 2022, then decreased by 19.67% to $3.5 million in 2023, then jumped by 30.93% to $4.5 million in 2024, then soared by 215.68% to $14.3 million in 2025, then plunged by 72.56% to $3.9 million in 2026.
- Business Quant data shows JAGX's Research & Development at $3.9 million in Q1 2026, $14.3 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -58.00 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 14.31 Mn |
| Sep 30, 2025 | 3.66 Mn |
| Jun 30, 2025 | 3.27 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 4.04 Mn |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 6.08 Mn |
| Jun 30, 2023 | 4.28 Mn |
| Mar 31, 2023 | 4.78 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 5.94 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 4.95 Mn |
| Dec 31, 2021 | 5.48 Mn |
| Sep 30, 2021 | 3.31 Mn |
| Jun 30, 2021 | 3.87 Mn |